Patent · US Active

Pyruvate kinase activators for use in treating blood disorders

US11364240B2 · kind B2 · utility

3Cited by

3References

27Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Giovanni Cianchetta · Waltham, US
Tao Liu · Shanghai, CN
Anil Kumar Padyana · Oxford, US
Zhihua Sui · Flemington, US
Zhenwei Cai · Skillman, US
Dawei Cui · Shanghai, CN
Jingjing Ji · Shanghai, CN

Key dates

Filing date	Aug 15, 2018
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Aug 15, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds that activate pyruvate kinase R, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I): wherein R1, R2, L1, and L2 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.